Coverage follows the use, not just the name.

Medicare has a special split

As of September 2026, Medicare drug coverage may not cover a medicine for weight loss even when it covers that medicine for another accepted use.

As of September 2026, Medicare runs a temporary program called the GLP-1 Bridge for certain weight-loss medicines. People who qualify pay $50 for a monthly supply through December 31, 2027.

To qualify, you must be at least 18, have Medicare drug coverage, and meet one of the program’s weight-and-health rules. Those rules start with a body mass index (BMI)—a measure based on height and weight—of at least 35, or a BMI of at least 27 or 30 plus certain health problems. Your doctor or other medical professional must prescribe the medicine and send the required approval form. People with type 2 diabetes use normal Part D coverage rather than this temporary program.

Ask the plan these questions

• Is this exact medicine covered for this diagnosed condition?
• Does the plan need to approve it before it will pay? Ask what your doctor or other medical professional must send.
• Which pharmacy must fill it?
• If I pay cash, does it count toward my deductible or yearly out-of-pocket limit?

Many cash offers and savings cards show an end date of December 31, 2026. A quoted price may change after that date.